Brain Scientific

Brain Scientific Stock-Based Compensation

The Stock-Based Compensation (SBC) of Brain Scientific (BRSF) as of Nov 17, 2026 is 3.57 M USD. In the previous year, Stock-Based Compensation (SBC) was 3.22 M USD — a change of 10.70% (higher).

Stock-Based Compensation

3.57 MUSD

YoY

10.70%

Last updated:

Stock-Based Compensation (SBC) of Brain Scientific is 2022 3.57 M USD. Stock-Based Compensation (SBC) of Brain Scientific was 2021 3.22 M USD. It decreases by 10.70% higher compared to the previous year.

The Brain Scientific Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2021
3.22 M USD
Jan 1, 2022
3.57 M USD
The Brain Scientific Stock-Based Compensation history
YEARStock-Based CompensationYoY
3.57 MUSD+10.70%
3.22 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Brain Scientific Stock analysis

What does Brain Scientific do? Brain Scientific Inc. generates revenue through its subsidiaries Memory MD, Inc. and Piezo Motion Corp., which offer complementary medical device and software solutions. Memory MD, Inc. focuses on neurology products including the NeuroCap, a disposable EEG cap with integrated electrodes designed to improve conventional EEG systems, and NeuroEEG, a wireless EEG system connecting to computers. Piezo Motion Corp. develops small piezoelectric motors and micro dosing pumps for medical devices and other industries, with twelve commercial motor platforms available. The company's products are sold to healthcare providers and medical device manufacturers seeking advanced neurology and motion technologies. The NeuroCap and NeuroEEG systems target neurology clinics and hospitals requiring efficient EEG data acquisition and analysis, while Piezo Motion Corp.'s motors serve medical device makers and industrial clients needing precise motion control. Memory MD, Inc.'s products address the neurology market segment, and Piezo Motion Corp. serves both medical device and non-medical device industries with its motion products. The company's centralized platform integrates EEG data acquisition with cloud-based telehealth services, enhancing its value proposition for healthcare providers. Brain Scientific Inc. monetizes its subsidiary products by selling medical devices, software, and motion components directly to healthcare institutions and manufacturers. Memory MD, Inc. provides neurology-specific solutions like the NeuroCap and NeuroEEG, while Piezo Motion Corp. offers piezoelectric motors and micro dosing pumps for diverse applications. The company's revenue streams are derived from these two distinct product lines, each serving specific market segments within the medical technology sector. Brain Scientific is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Brain Scientific stock

Stock-Based Compensation (SBC) of Brain Scientific is 3.57 M USD in 2022.

Stock-Based Compensation (SBC) of Brain Scientific changed from 3.22 M USD to 3.57 M USD, representing a 10.70% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Brain Scientific since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Brain Scientific historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Brain Scientific

All Key Metrics — Brain Scientific